These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 14332642)

  • 1. INVESTIGATIONS INTO THE ETIOLOGY OF DERMATITIS HERPETIFORMIS. II. THE EFFECTS OF SERUM FROM DERMATITIS HERPETIFORMIS CASES AND OF CERTAIN DRUGS ON THE VISCOSITY REDUCTION PROPERTY OF HYALURONIDASE.
    ALEXANDER JO
    J Invest Dermatol; 1965 Aug; 45():73-7. PubMed ID: 14332642
    [No Abstract]   [Full Text] [Related]  

  • 2. Investigations into the etiology of dermatitis herpetiformis. 1. The effects of serum from dermatitis herpetiformis cases on the spreading property of hvaluronidase.
    ALEXANDER JO
    J Invest Dermatol; 1961 Jul; 37():39-49. PubMed ID: 13682345
    [No Abstract]   [Full Text] [Related]  

  • 3. THE TREATMENT OF DERMATITIS HERPETIFORMIS WITH HEPARIN.
    ALEXANDER JO
    Br J Dermatol; 1963 Jul; 75():289-93. PubMed ID: 14046150
    [No Abstract]   [Full Text] [Related]  

  • 4. [Agranulocytosis induced by dapsone prescribed for dermatitis herpetiformis].
    Machet L; Callens A; Mercier E; Gargot S; Lorette G; Vaillant L
    Ann Dermatol Venereol; 1996; 123(5):328-30. PubMed ID: 8761086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An unusual complication associated with dapsone therapy of dermatitis herpetiformis.
    ALEXANDER JO
    Scott Med J; 1958 May; 3(5):212-3. PubMed ID: 13555949
    [No Abstract]   [Full Text] [Related]  

  • 6. Dermatitis herpetiformis.
    Zone JJ; Meyer LJ
    Immunol Ser; 1989; 46():565-82. PubMed ID: 2488870
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic use of dapsone in dermatitis herpetiformis (Duhring) and in certain inflammatory skin diseases].
    Révész K; Schneider I
    Orv Hetil; 1995 Jan; 136(2):59-62. PubMed ID: 7862431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. INHIBITION OF EXUDATE PRODUCTION BY ANTI-INFLAMMATORY DRUGS.
    LASKIN DM; KOLODNY SC
    J Oral Ther Pharmacol; 1965 Jan; 1():383-91. PubMed ID: 14232387
    [No Abstract]   [Full Text] [Related]  

  • 9. A rare case of dermatitis herpetiformis requiring parenteral heparin for long-term control.
    Tan CC; Sale JE; Brammer C; Irons RP; Freeman JG
    Dermatology; 1996; 192(2):185-6. PubMed ID: 8829511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dapsone for treatment of pruritic dermatitis (dermatitis herpetiformis and subcorneal pustular dermatosis) in dogs.
    Halliwell RE; Schwartzman RM; Ihrke PJ; Goldschmidt MH; Wood MG
    J Am Vet Med Assoc; 1977 Apr; 170(7):697-703. PubMed ID: 858685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dapsone in dermatitis herpetiformis.
    MORGAN JK; MARSDEN CW; COBURN JG; MUNGAVIN JM
    Lancet; 1955 Jun; 268(6876):1197-1200. PubMed ID: 14382544
    [No Abstract]   [Full Text] [Related]  

  • 12. [On iodine sensitivity in Duhring's dermatitis herpetiformis; the epicutaneous potassium iodide test as a nonspecific example of the Hofmeister anion effect].
    SPIER HW; SCHIRREN CG; DESSIN U; EWINGER T
    Arch Dermatol Syph; 1952; 195(2):105-37. PubMed ID: 13031541
    [No Abstract]   [Full Text] [Related]  

  • 13. Dapsone and human polymorphonuclear leucocyte chemotaxis in dermatitis herpetiformis.
    Millar BW; Macdonald KJ; Macleod TM; Raffle EJ
    Acta Derm Venereol; 1984; 64(5):433-6. PubMed ID: 6208726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dapsone in the treatment of dermatitis herpetiformis.
    ALEXANDER JO
    Lancet; 1955 Jun; 268(6876):1201-2. PubMed ID: 14382545
    [No Abstract]   [Full Text] [Related]  

  • 15. The protective effect of vitamin E on the hemolysis associated with dapsone treatment in patients with dermatitis herpetiformis.
    Prussick R; Ali MA; Rosenthal D; Guyatt G
    Arch Dermatol; 1992 Feb; 128(2):210-3. PubMed ID: 1739299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between dapsone dose, serum concentration and disease severity in dermatitis herpetiformis.
    Sanders SW; Zone JJ
    Arzneimittelforschung; 1986; 36(1):146-9. PubMed ID: 3954818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermatitis herpetiformis effectively treated with heparin, tetracycline and nicotinamide.
    Shah SA; Ormerod AD
    Clin Exp Dermatol; 2000 May; 25(3):204-5. PubMed ID: 10844495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discontinuing dapsone treatment and reintroducing dietary gluten in patients with dermatitis herpetiformis in remission: comment on "remission in dermatitis herpetiformis".
    Mostow EN
    Arch Dermatol; 2011 Mar; 147(3):305-6. PubMed ID: 21422338
    [No Abstract]   [Full Text] [Related]  

  • 19. Neurologic symptoms posing as dapsone-induced polyneuropathy in two patients with dermatitis herpetiformis.
    Fernandez-Obregon AC; Forconi RJ
    Cutis; 1988 May; 41(5):347-50. PubMed ID: 2836133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Juvenile dermatitis herpetiformis: an immunologically proven case.
    Hertz KC; Katz SI
    Pediatrics; 1977 Jun; 59(6):945-8. PubMed ID: 865949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.